Publications by authors named "James Starling"

Claim this Profile
P
Predicting energy intake in adults who are dieting and exercising.
Corey Gerving, Robert Lasater, James Starling, Danielle M Ostendorf, Leanne M Redman

Int J Obes (Lond)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120.
Shih-Hsun Chen, Youyan Zhang, Robert D Van Horn, Tinggui Yin, Sean Buchanan, James J Starling

Cancer Discov· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.
Sheng-Bin Peng, James R Henry, Michael D Kaufman, Wei-Ping Lu, Bryan D Smith, James J Starling

Cancer Cell· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a pan-RAF inhibitor with minimal paradoxical activation and activity against BRAF or RAS mutant tumor cells.
James R Henry, Michael D Kaufman, Sheng-Bin Peng, Yu Mi Ahn, Timothy M Caldwell, James J Starling

J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation.
Vipin Yadav, Teresa F Burke, Lysiane Huber, Robert D Van Horn, Youyan Zhang, James J Starling

Mol Cancer Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models.
Tinggui Yin, Maria J Lallena, Emiko L Kreklau, Kevin R Fales, Santiago Carballares, James J Starling

Mol Cancer Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity.
Robert M Campbell, Bryan D Anderson, Nathan A Brooks, Harold B Brooks, Edward M Chan, James J Starling

Mol Cancer Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.
Susan E Pratt, Sara Durland-Busbice, Robert L Shepard, Gregory P Donoho, James J Starling

Mol Cancer Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical assessment of carcinogenic risk and tumor growth enhancement potential of prasugrel, a platelet-inhibiting therapeutic agent.
Lorrene A Buckley, Atsushi Sanbuissho, James J Starling, Mary Pat Knadler, Philip W Iversen

Int J Toxicol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma.
Vipin Yadav, Xiaoyi Zhang, Jiangang Liu, Shawn Estrem, Shuyu Li, James J Starling

J Biol Chem· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model.
Timothy P Burkholder, Joshua R Clayton, Mark E Rempala, James R Henry, John M Knobeloch, James J Starling

Invest New Drugs· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up after meshectomy with acellular human dermis repair for postherniorrhaphy inguinodynia.
Matthew C Koopmann, Brett H Yamane, James R Starling

Arch Surg· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.
David M Bender, Jingqi Bao, Anne H Dantzig, William D Diseroad, Kevin L Law, James J Starling

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model.
Yuefeng Chen, Tao Wei, Lei Yan, Frank Lawrence, Hui-Rong Qian, James J Starling

BMC Genomics· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications.
Kenji Ishitsuka, Teru Hideshima, Paola Neri, Sonia Vallet, Norihiko Shiraishi, James J Starling

Br J Haematol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic benign multinodular goiter: unilateral or bilateral thyroidectomy?
Sarah E Olson, James Starling, Herbert Chen

Surgery· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does frozen section alter surgical management of multinodular thyroid disease?
Sarah Olson, Yusra Cheema, Josephine Harter, James Starling, Herbert Chen

J Surg Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
Jon C Gould, Michael J Garren, Valerie Boll, James R Starling

Surgery· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of circular stapler diameter on the incidence of gastrojejunostomy stenosis and weight loss following laparoscopic Roux-en-Y gastric bypass.
Jon Charles Gould, Michael Garren, Valerie Boll, James Starling

Surg Endosc· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-needle aspiration optimizes surgical management in patients with thyroid cancer.
David Y Greenblatt, Todd Woltman, Josephine Harter, James Starling, Eberhard Mack

Ann Surg Oncol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
Susan Pratt, Victor Chen, William I Perry, James J Starling, Anne H Dantzig

Eur J Pharm Sci· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1).
Bryan H Norman, Peter A Lander, Joseph M Gruber, Julian S Kroin, Jeffrey D Cohen, James J Starling

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation.
Silke V Haustein, Eberhard Mack, James R Starling, Herbert Chen

Surgery· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 25-year single institution analysis of health, practice, and fate of general surgeons.
Bruce A Harms, Charles P Heise, Jon C Gould, James R Starling

Ann Surg· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy.
Herbert Chen, Zachary Pruhs, James R Starling, Eberhard Mack

Surgery· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis